Starpharma Holdings Ltd VP Dr Malcolm McColl Appointed CEO of Viralytics Ltd
11/14/2012 7:27:15 AM
More...
|
Viralytics Ltd Receives Approval To Increase CAVATAK(TM) Dosage Levels In Intravenous Cancer Trial
4/20/2009 12:05:57 PM
More...
|
Viralytics Ltd Strengthens US Patent Portfolio
3/30/2009 12:56:18 PM
More...
|
Viralytics Ltd Release: Pre-Clinical Research On EVATAKTM In Human Gastric (Stomach) Cancer Accepted For Publication
12/19/2008 10:37:16 AM
More...
|
Viralytics Ltd Positive Pre-Clinical Research Results On CAVATAK(TM) In Human Brain Cancer
12/12/2008 10:02:36 AM
More...
|
Viralytics Ltd to Test CAVATAK(TM) in Head and Neck Cancer
12/9/2008 1:02:18 PM
More...
|
Viriathus Research Issues an Overview Report for Viralytics Ltd
11/25/2008 10:28:01 AM
More...
|
Viralytics Ltd Secures Key EU Patent
10/24/2008 11:18:04 AM
More...
|
Haynes Capital Corp. Hosts Professor Darren Shafren and Dr. Stephen Lambros of Viralytics Ltd
3/13/2007 12:50:58 PM
More...
|